Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $759.39 | 1 | 57.1% |
| Food and Beverage | $570.59 | 10 | 42.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $1,011 | 5 | $0 (2019) |
| Gilead Sciences, Inc. | $124.76 | 1 | $0 (2019) |
| ABBVIE INC. | $120.08 | 1 | $0 (2024) |
| Lilly USA, LLC | $59.62 | 3 | $0 (2023) |
| Allergan Inc. | $14.22 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120.08 | 1 | ABBVIE INC. ($120.08) |
| 2023 | $18.75 | 1 | Lilly USA, LLC ($18.75) |
| 2022 | $40.87 | 2 | Lilly USA, LLC ($40.87) |
| 2019 | $1,136 | 6 | Lundbeck LLC ($1,011) |
| 2017 | $14.22 | 1 | Allergan Inc. ($14.22) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/30/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $120.08 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Neuroscience | ||||||
| 12/19/2022 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Neuroscience | ||||||
| 08/08/2022 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Neuroscience | ||||||
| 03/01/2019 | Lundbeck LLC | NORTHERA (Drug) | Travel and Lodging | Cash or cash equivalent | $759.39 | General |
| Category: NEUROLOGY | ||||||
| 02/28/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $124.76 | General |
| 02/27/2019 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $76.67 | General |
| Category: NEUROLOGY | ||||||
| 02/26/2019 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $84.84 | General |
| Category: NEUROLOGY | ||||||
| 02/26/2019 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $65.90 | General |
| Category: NEUROLOGY | ||||||
| 02/25/2019 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $24.50 | General |
| Category: NEUROLOGY | ||||||
| 02/06/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Stuart Isaacson, DO
Dr. Stuart Isaacson, DO is a Occupational Medicine healthcare provider based in West Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1710007398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Isaacson, DO has received a total of $1,330 in payments from pharmaceutical and medical device companies, with $120.08 received in 2024. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($759.39).
Practice Information
- Specialty Occupational Medicine
- Other Specialties Family Medicine
- Location West Lafayette, IN
- Active Since 03/29/2007
- Last Updated 06/20/2017
- Taxonomy Code 2083X0100X
- Entity Type Individual
- NPI Number 1710007398
Products in Payments
- NORTHERA (Drug) $1,011
- DUOPA (Drug) $120.08
- AMYVID (Drug) $59.62
- NAMZARIC (Drug) $14.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.